This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Opioid CDS Recommendation 7 ECA Rule (id = "opioidcds-07")
<?xml version="1.0" encoding="UTF-8"?> <PlanDefinition xmlns="http://hl7.org/fhir"> <id value="opioidcds-07"/> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="cds"/> </extension> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.11.6"/> </identifier> <identifier> <use value="official"/> <value value="cdc-opioid-guidance"/> </identifier> <version value="0.1.0"/> <name value="Cdcopioid07"/> <title value="CDC Opioid Prescribing Guideline Recommendation #7"/> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/> <code value="eca-rule"/> <display value="ECA Rule"/> </coding> </type> <status value="draft"/> <date value="2018-03-19"/> <publisher value="HL7 International / Clinical Decision Support"/> <contact> <telecom> <system value="url"/> <value value="http://www.hl7.org/Special/committees/dss"/> </telecom> </contact> <description value="Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for chronic pain or of dose escalation. Clinicians should evaluate benefits and harms of continued therapy with patients every 3 months or more frequently."/> <useContext> <code> <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/> <code value="focus"/> <display value="Clinical Focus"/> </code> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct"/> <code value="182888003"/> <display value="Medication requested (situation)"/> </coding> </valueCodeableConcept> </useContext> <useContext> <code> <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/> <code value="focus"/> <display value="Clinical Focus"/> </code> <valueCodeableConcept> <coding> <system value="http://snomed.info/sct"/> <code value="82423001"/> <display value="Chronic pain (finding)"/> </coding> </valueCodeableConcept> </useContext> <jurisdiction> <coding> <system value="urn:iso:std:iso:3166"/> <code value="US"/> <display value="United States of America"/> </coding> </jurisdiction> <purpose value="CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care."/> <usage value="If benefits do not outweigh harms of continued opioid therapy, clinicians should optimize other therapies and work with patients to taper opioids to lower dosages or to taper and discontinue opioids."/> <copyright value="© CDC 2016+."/> <topic> <text value="Opioid Prescribing"/> </topic> <author> <name value="Kensaku Kawamoto, MD, PhD, MHS"/> </author> <author> <name value="Bryn Rhodes"/> </author> <author> <name value="Floyd Eisenberg, MD, MPH"/> </author> <author> <name value="Robert McClure, MD, MPH"/> </author> <relatedArtifact> <type value="documentation"/> <display value="CDC guideline for prescribing opioids for chronic pain"/> <document> <url value="https://guidelines.gov/summaries/summary/50153/cdc-guideline-for-prescribing-opioids-for-chro nic-pain---united-states-2016#420"/> </document> </relatedArtifact> <relatedArtifact> <type value="documentation"/> <display value="MME Conversion Tables"/> <document> <url value="https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf"/> </document> </relatedArtifact> <library value="http://example.org/fhir/Library/opioidcds-recommendation-07"/> <action> <extension url="http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation"> <valueCodeableConcept> <coding> <system value="http://terminology.hl7.org/CodeSystem/recommendation-strength"/> <code value="strong"/> <display value="Strong"/> </coding> </valueCodeableConcept> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/cqf-qualityOfEvidence"> <valueCodeableConcept> <coding> <system value="http://terminology.hl7.org/CodeSystem/evidence-quality"/> <code value="low"/> <display value="Low quality"/> </coding> </valueCodeableConcept> </extension> <title value="Existing patient should be evaluated for risk of continued opioid therapy."/> <description value="Checking if the trigger prescription meets the inclusion criteria for recommendation #7 workflow."/> <documentation> <type value="documentation"/> </documentation> <trigger> <type value="named-event"/> <name value="medication-prescribe"/> </trigger> <condition> <kind value="applicability"/> <expression> <description value="Check whether the existing patient, without an end of life condition or risk assessment in the past 90 days, has taken an opioid-with-abuse-potential for 7 of the past 10 days or 63 of the past 90 days."/> <language value="text/cql"/> <expression value="Inclusion Criteria"/> </expression> </condition> <groupingBehavior value="visual-group"/> <selectionBehavior value="exactly-one"/> <dynamicValue> <path value="action.title"/> <expression> <language value="text/cql"/> <expression value="Get Summary"/> </expression> </dynamicValue> <dynamicValue> <path value="action.description"/> <expression> <language value="text/cql"/> <expression value="Get Detail"/> </expression> </dynamicValue> <dynamicValue> <path value="action.extension"/> <expression> <language value="text/cql"/> <expression value="Get Indicator"/> </expression> </dynamicValue> <action> <description value="Will schedule assessment of risk for opioid use for the patient"/> </action> <action> <description value="Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo"/> </action> <action> <description value="N/A - see comment; snooze 3 mo"/> </action> </action> </PlanDefinition>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-ballot2 generated on Thu, Dec 12, 2024 19:29+0000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change